Genmab A/S (GMAB)

Basic

  • Market Cap

    DKK 131.72B

  • EV

    DKK 104.35B

  • Shares Out

    65.3M

  • Revenue

    DKK 16.47B

  • Employees

    2,204

Margins

  • Gross

    98.63%

  • EBITDA

    33.76%

  • Operating

    32.3%

  • Pre-Tax

    34.22%

  • Net

    26.42%

  • FCF

    42.58%

Returns (5Yr Avg)

  • ROA

    13.67%

  • ROTA

    20.3%

  • ROE

    19.89%

  • ROCE

    23.3%

  • ROIC

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    DKK 2,449.22

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    DKK 28.14B

  • Net Debt

    -DKK 27.37B

  • Debt/Equity

    0.02

  • EBIT/Interest

    197.07

Growth (CAGR)

  • Rev 3Yr

    17.67%

  • Rev 5Yr

    40.35%

  • Rev 10Yr

    37.88%

  • Dil EPS 3Yr

    -2.94%

  • Dil EPS 5Yr

    22.71%

  • Dil EPS 10Yr

    47.55%

  • Rev Fwd 2Yr

    19.45%

  • EBITDA Fwd 2Yr

    25.08%

  • EPS Fwd 2Yr

    25.91%

  • EPS LT Growth Est

    20.62%

Dividends

  • Yield

  • Payout

  • DPS

  • DPS Growth 3Yr

  • DPS Growth 5Yr

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

Total Revenues

5,366

10,111

8,417

14,505

16,474

Total Revenues % Chg.

77.4%

88.4%

-16.8%

72.3%

13.6%

Cost of Goods Sold, Total

226

Gross Profit

5,366

10,111

8,417

14,505

16,248

Selling General & Admin Expenses, Total

342

661

1,283

2,676

3,297

R&D Expenses

2,386

3,137

4,181

5,524

7,630

Other Operating Expenses, Total

2,728

3,798

5,464

8,200

10,927

Operating Income

2,638

6,313

2,953

6,305

5,321

Interest Expense, Total

-7

-10

-13

-21

-27

Interest And Investment Income

120

184

197

324

939

Net Interest Expenses

113

174

184

303

912

Currency Exchange Gains (Loss)

99

-1,456

1,470

1,034

-889

Other Non Operating Income (Expenses)

EBT, Excl. Unusual Items

2,850

5,031

4,607

7,642

5,344

Gain (Loss) On Sale Of Investments

9

873

-689

-659

293

Asset Writedown

-38

Other Unusual Items

EBT, Incl. Unusual Items

2,859

5,904

3,918

6,945

5,637

Income Tax Expense

693

1,146

961

1,493

1,285

Earnings From Continuing Operations

2,166

4,758

2,957

5,452

4,352

Net Income

2,166

4,758

2,957

5,452

4,352

Net Income to Common Incl Extra Items

2,166

4,758

2,957

5,452

4,352

Net Income to Common Excl. Extra Items

2,166

4,758

2,957

5,452

4,352

Total Shares Outstanding

64.9

65.4

65.4

65.4

65.3

Weighted Avg. Shares Outstanding

63

65.2

65.4

65.4

65.3

Weighted Avg. Shares Outstanding Dil

63.6

65.9

66

66

65.9

EPS

34.4

73

45.2

83.4

66.6

EPS Diluted

34

72.2

44.8

82.6

66

EBITDA

2,777

6,543

3,147

6,521

5,561